ArticleUpdates in surgery2025
A nomogram based on PNI and preoperative TACE can predict overall survival in patients with larger than 2 cm HCC after hepatectomy.
Article in Updates in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study was to construct a nomogram based on prognostic nutritional index (PNI) and preoperative transcatheter arterial chemoembolization (TACE) to predict the overall survival (OS) of patients with hepatocellular carcinoma (HCC) larger than 2 cm after hepatectomy. 307 and 131 patients were included in the development and validation sets, respectively. The clinical endpoint was OS. Univariate and multivariate Cox regression analyses were used in the development set to screen independent risk factors for clinical endpoints. Independent risk factors were used to construct a nomogram. The C-index, calibration curves, and decision analysis curves were used to evaluate the predictive power of the nomogram in the development and validation sets. After univariate and multivariate Cox regression analysis, independent risk factors for OS included preoperative TACE, age, Barcelona Clinic Liver Cancer (BCLC) stage, PNI, tumor longest diameter, and alpha-fetoprotein (AFP). In the development set and the validation set, the C-index of the nomograms was 0.662 (95% confidence interval (CI): 0.624-0.699) and 0.659 (95% CI: 0.600-0.719), respectively. Calibration curves and decision analysis curves showed that the nomogram had an effective predictive ability. The nomogram based on PNI and preoperative TACE can effectively predict the OS of patients with HCC larger than 2 cm after hepatectomy.
Indexed as
Identifiers
40323534What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.